The inherent challenges of drug discovery and development require tailored management when pursued as part of a joint effort from strategic alliance partners. This session will survey industry best practices for managing and mitigating risks in biotech and biopharmaceutical alliances. Presenters will explore options for how to actively manage the risks for each partner and the alliance overall in order to create a win-win-win situation. The session will also highlight some commonly overlooked risks and feature a general risk management framework for alliance managers.
Session will include active audience participation through a series of questions exploring how alliance leaders are managing and communicating risk.
Participants should expect to come away with:
Chris Roenfeldt, CA-AM
Senior Director, Alliance Management
Jason Felsch, CA-AM, PhD
Strategy & Business Development